Lysosomal transport of cargos in neurons is essential for neuronal proteostasis, transmission and functional motors and behaviours. Lysosomal malfunction including storage disorders is involved in the pathogenesis of Parkinson's disease (PD). Given the unclear molecular mechanisms of diverse defects in PD phenotypes, especially behavioural deficits, this mini review explores the cellular contexts of PD impulse control disorders and the molecular aspects of lysosomal cross-membrane transports. Focuses are paid to trace metal involvements in α-synuclein assembly in Lewy bodies, the func- The progressive neurodegeneration of specific brain regions has been shown to be associated with eosinophilic inclusions (Lewy bodies) in the neurons, resulting in reduced levels of DA in the striatum, loss of neuronal function, degeneration and death. Although dopaminergic neurotransmitter therapy can cause partial remission, it can also cause side effects including behavioural abnormalities.
| INTRODUCTION
Parkinson's disease (PD) characteristic of movement disorders (resting tremor, rigidity, bradykinesia or gait disorders) is a common degenerative disease of the nervous system following the senile dementia caused by chronic lesion of the central nervous system (CNS). Numerous studies have shown that the pathological basis of PD is related to dopamine (DA) neuronal degenerative injury in midbrain substantia nigra (SN).
The progressive neurodegeneration of specific brain regions has been shown to be associated with eosinophilic inclusions (Lewy bodies) in the neurons, resulting in reduced levels of DA in the striatum, loss of neuronal function, degeneration and death. Although dopaminergic neurotransmitter therapy can cause partial remission, it can also cause side effects including behavioural abnormalities.
1,2
Parkinson's disease patients present the symptoms of behavioural disorder that include excessive eating, frequent sexual activity and other compulsive actions, characteristic of involuntary impulse control disorders that are clinically known as the impulse control disorder (ICD). [2] [3] [4] Although its pathogenesis is unknown, ICD has been reported to be a common behavioural disorder accounting for 3% of adults usually in the youth stage 5 and 25%-50% in PD patients. [6] [7] [8] Clinical diagnosis of ICD depends on interrogation assessment, and apparently there is no effective treatment. [6] [7] [8] Understanding of the pathological changes of PD and ICD involves clarification of the concurrences of abnormal behaviour and movement mediated by convergent interactions between genetic and environmental factors on specified neurotransmitter circuits of particular brain regions.
| THE CHARACTERISTICS OF PD ICD
Impulsive control of behaviour is an important mechanism in the regulation of human and animal physiological behaviours, and is the result of the survival and evolution of social animals. For centuries, people have been puzzled of the abnormal behaviours of impulsive control. 5 Although common in young people, excessive impulse also occurs in adulthood and even lasts for a lifetime as ICD syndrome. [6] [7] [8] The spectrums of ICD include more mating behaviour, more eating, hair pulling disorder (trichotillomania, TTM), nail biting (onychophagia) and skin picking disorder (dermatillomania). 3, [9] [10] [11] [12] [13] [14] [15] Whereas the predominant symptoms in males appear to be hypersexuality, 8, 9, [16] [17] [18] [19] [20] female patients commonly show TTM, nail biting and or skin picking. [21] [22] [23] [24] [25] Intriguingly, PD patients with ICD are usually young having familial PD, neuropsychiatric disorders or gambling history, 3 and can have two or more ICD symptoms coexisting.
19,20,26
The genetic and molecular features of PD ICD are unknown.
Studies suggest that ICD pathogenesis is related to a dysfunction of the neural circuits involving the prefrontal cortex (or orbital front cortex, OFC) and the striatum. Neural imaging studies of PD patients showed ventral OFC dysfunctions 2,27-29 with attenuated activity of OFC in a top-down control pathway. 30 In addition, the striatal ventral limbic system appears hyperactivity leading to hyper-impulsive signals. 31 Measuring neurotransmissions suggests that in the OFC, decreased serotonin (5-HT) results in weakened inhibition over impulses for incentives. 32, 33 The repression known as reversal learning is an essential mechanism of behavioural flexibility, which depends on the integrity of the OFC-striatal circuit. The selective serotonin reuptake inhibitor (SSRI) fluoxetine inhibition of 5-HT synaptic reuptake has been demonstrated to increase reverse learning and relieve ICD symptoms. 27, [32] [33] [34] [35] [36] A major issue in the use of dopamine to treat PD is a resultant increase in ICD, suggesting that increased DA receptor activity in the brain limbic system is associated with ICD. 1, 26 Some studies have shown that D3 receptor activity is involved in mediating ICD, 37 although others suggest that it requires further study to confirm. 38, 39 In addition, increased glutamate may be involved in connecting amygdale, hypothalamus, cingulate gyrus and OFC to promote hypersexuality, [40] [41] [42] repeated hair pulling 43, 44 and anxiety. 45 Thus, the regulation by 5-HT receptors activity in the OFC of dopamine and/or glutamate activities in the ventral striatum and cingulate regions may be a part of the mechanism of impulse regulation over reward-entrancing behaviours.
| LEWY BODIES, α -SYNUCLEIN AND CU

2+
Neural degeneration selectively occurs to certain populations of neu- Thus, α-synuclein forms an insoluble fibrous structure in PD with Lewy body dementia and multiple systemic sclerosis.
60,61
How α-synuclein is assembled from soluble monomers in physiological status into fibrous structures of Lewy bodies under the pathological conditions remains elusive. Recent studies have demonstrated that acetylation of α-synuclein at the amino terminus results in a compact structure, preventing the non-β-amyloid aggregation domains from being exposure and thus precluding spontaneous aggregation.
62
When α-synuclein forms an insoluble fibrous structure, there are mutually overlapping β-sheets with a hydrophobic core and diverse complex configurations in its amyloid structure. 60 Each of these complexes consists of an intermolecular metal ion bridge, glutamine-bound ladders, and zipper-like structures to stabilize a predominantly β-sheet composed structure of orthorhombic Greek pattern.
60
The metal ion bridge in this complex is of particular interest given the elevated levels of copper (Cu
2+
) and manganese (Mn (Figure 1 ). 
| LYSOSOMAL HANDLING OF TRACE METALS AND LIPIDS
| ATP13A2 GENE MUTATION
The ATP13A2 gene is a recessive mutation disease-causing gene at chromosome 1p36 of early-onset young PD patients with dementia.
It encodes 1180 amino acids and contains 10 hydrophobic transmembrane regions. ATP13A2 as a P-type transporter plays an important role in the regulation of Mn 2+ homeostasis. 103 In PD patients, multiple ATP13A2 gene mutations have been identified. 104 In primary cultured rat neurons, the wild-type ATP13A2 protects the cells from the toxic effects of Mn 2+ and reduces the release of cytochrome c from the mitochondria, but its pathogenic mutants have no such ability, suggesting that ATP13A2 is essential against Mn 2+ cytotoxicity by regulating the cell Mn 2+ homeostasis. 105 Knockdown of ATP13A2 expression in cultured neurons and cerebral cortical neurons results in F I G U R E 2 Lysosome integrations of cytoplasmic clearance of toxicity, stress-stimulated metabolisms and related gene expressions. Lysosomal membranes are equipped with various ATPase pumps, ion channels and amino acid channels, and are also bound by GTPases and their regulatory proteins. (A) Under non-stress conditions, TSC2 is involved in stimulating Rheb GTPase activity rendering Rheb in GDPbound conformation, TPC pumps out Na + , and ATP13A2 might pumps in Mn
2+
, together in favor of mTOR inactivation. (B) When ATP13A2 becomes deficient as in PD conditions, TSC2 is ubiquitinated and degraded by proteasomes, rendering Rheb in GTP-bound confirmation, and SLC38 pumps out amino acids to activate Akt, CASTOR, LRS and FLCN, together resulting in mTOR activation in association with lysosomes and lysosomal transcription factor TFEB inhibition. Thus, lysosomal dysfunctions in trafficking and autophagy can be induced with lysosomal dyshomeostasis by ATP13A2 mutation-associated cross-membrane transport, TSC2 deficiency-induced mTOR activation and suppression of TFEB transcription factor-induced gene transcriptions for lysosomal proteins. Mn denotes manganese and AA denotes amino acids the generation of large amounts of ROS and mitochondrial dysfunction. 106 As a metal transporter, however, ATP13A2 corresponding specificity for trace metal ligand and its mechanisms of action have not been fully understood.
107
In the yeast cell knockout of the ypk9 gene (ATP13A2 homologous gene), its growth was affected by particular metal ions, such as cadmium, selenium, manganese and nickel, which suggested that ATP13A2 is related to the transport of these ions. 108 Among them, Mn 2+ ion is one of the most toxic trace elements that are known to be toxic to neurons. 108 
